Wegener's granulomatosis

GPTKB entity

Statements (73)
Predicate Object
gptkbp:instance_of gptkb:candy
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:granulomatosis_with_polyangiitis
gptkbp:affects lungs
blood vessels
the nervous system
the heart
the gastrointestinal tract
the eyes
gptkbp:can_be gptkb:musician
gptkbp:can_lead_to hearing loss
sepsis
chronic kidney disease
kidney damage
pulmonary complications
life-threatening complications
pulmonary hemorrhage
gptkbp:caused_by dizziness
fatigue
weight loss
abdominal pain
inflammation
joint pain
peripheral neuropathy
chronic cough
thrombosis
respiratory symptoms
myalgia
gptkbp:first_described_by gptkb:Friedrich_Wegener
https://www.w3.org/2000/01/rdf-schema#label Wegener's granulomatosis
gptkbp:is_a gptkb:healthcare_organization
gptkbp:is_associated_with gptkb:fandom
pulmonary fibrosis
increased risk of infections
renal failure
increased mortality risk
other autoimmune diseases
pulmonary nodules
ANCA antibodies
scleritis
gptkbp:is_characterized_by chronic inflammation
multisystem involvement
systemic symptoms
granulomatous inflammation
chronic cough and hemoptysis
necrotizing granulomas
systemic vasculitis
gptkbp:is_involved_in skin lesions
gptkbp:is_known_for gptkb:granulomatosis_with_polyangiitis
gptkbp:is_monitored_by blood tests
gptkbp:is_often_used_in middle-aged individuals
gptkbp:is_used_for fever
sinusitis
joint swelling
skin ulcers
hemoptysis
nasal obstruction
oral ulcers
gptkbp:requires gptkb:hospital
long-term follow-up
gptkbp:scientific_classification small vessel vasculitis
gptkbp:social_responsibility imaging studies
clinical evaluation
biopsy
ANCA testing
gptkbp:treatment gptkb:methotrexate
gptkb:cyclophosphamide
gptkb:rituximab
corticosteroids
plasma exchange
immunosuppressive therapy
biologic agents
gptkbp:type_of gptkb:musician